BMIDX
Price
$17.23
Change
+$0.15 (+0.88%)
Updated
Nov 8 closing price
FSMAX
Price
$94.94
Change
+$0.66 (+0.70%)
Updated
Nov 8 closing price
Ad is loading...

BMIDX vs FSMAX

Header iconBMIDX vs FSMAX Comparison
Open Charts BMIDX vs FSMAXBanner chart's image
Brown Advisory Mid-Cap Growth Investor
Price$17.23
Change+$0.15 (+0.88%)
VolumeN/A
CapitalizationN/A
Fidelity Extended Market Index
Price$94.94
Change+$0.66 (+0.70%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
BMIDX vs FSMAX Comparison Chart
Loading...
VS
BMIDX vs. FSMAX commentary
Nov 10, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMIDX is a StrongBuy and FSMAX is a Buy.

FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 40B vs. BMIDX (105M). FSMAX pays higher dividends than BMIDX: FSMAX (1.10) vs BMIDX (0.00). BMIDX was incepted earlier than FSMAX: BMIDX (7 years) vs FSMAX (13 years). BMIDX is a more actively managed with annual turnover of: 55.00 vs. FSMAX (18.00). FSMAX has a lower initial minimum investment than BMIDX: FSMAX (0) vs BMIDX (100). FSMAX annual gain was more profitable for investors over the last year : 45.37 vs. BMIDX (37.84). FSMAX return over 5 years is better than : 56.24 vs. BMIDX (30.93).
BMIDXFSMAXBMIDX / FSMAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence7 years13 years-
Gain YTD18.74621.62487%
Front LoadN/AN/A-
Min. Initial Investment1000-
Min. Initial Investment IRAN/AN/A-
Net Assets105M40B0%
Annual Yield % from dividends0.001.10-
Returns for 1 year37.8445.3783%
Returns for 3 years-15.832.38-665%
Returns for 5 years30.9356.2455%
Returns for 10 yearsN/A86.33-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BHR3.390.27
+8.65%
Braemar Hotels & Resorts
ATAT26.55-0.15
-0.56%
Atour Lifestyle Holdings Limited
EFSH0.24N/A
-0.95%
1847 Holdings LLC
RPRX26.21-0.31
-1.17%
Royalty Pharma plc
FLGT19.43-2.59
-11.76%
Fulgent Genetics